Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norethindrone Acetate vs Lupron Depot in Endometriosis
NCT00458458Phase 3Unknown
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Aug 2004
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of norethisterone acetate in endometriosis (2 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoints: Effectiveness in relieving symptoms of endometriosis at 24 weeks and Bone density at 52 weeks. Status: unknown.
02
Drugs
norethisterone acetate
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT00458458.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00458458.